Teva Pharmaceutical Industries Ltd (TEVA)
17.08
+0.06
(+0.32%)
USD |
NYSE |
Nov 21, 16:00
17.08
0.00 (0.00%)
After-Hours: 16:29
Teva Pharmaceutical Industries Price to Book Value: 3.192 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.182 |
| November 19, 2024 | 3.140 |
| November 18, 2024 | 3.081 |
| November 15, 2024 | 3.069 |
| November 14, 2024 | 3.129 |
| November 13, 2024 | 3.165 |
| November 12, 2024 | 3.196 |
| November 11, 2024 | 3.245 |
| November 08, 2024 | 3.196 |
| November 07, 2024 | 3.269 |
| November 06, 2024 | 3.256 |
| November 05, 2024 | 3.507 |
| November 04, 2024 | 3.482 |
| November 01, 2024 | 3.447 |
| October 31, 2024 | 3.445 |
| October 30, 2024 | 3.473 |
| October 29, 2024 | 3.443 |
| October 28, 2024 | 3.432 |
| October 25, 2024 | 3.344 |
| October 24, 2024 | 3.409 |
| October 23, 2024 | 3.439 |
| October 22, 2024 | 3.434 |
| October 21, 2024 | 3.396 |
| October 18, 2024 | 3.353 |
| October 17, 2024 | 3.355 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.366 |
| October 15, 2024 | 3.391 |
| October 14, 2024 | 3.221 |
| October 11, 2024 | 3.223 |
| October 10, 2024 | 3.252 |
| October 09, 2024 | 3.312 |
| October 08, 2024 | 3.275 |
| October 07, 2024 | 3.228 |
| October 04, 2024 | 3.267 |
| October 03, 2024 | 3.247 |
| October 02, 2024 | 3.262 |
| October 01, 2024 | 3.301 |
| September 30, 2024 | 3.366 |
| September 27, 2024 | 3.111 |
| September 26, 2024 | 3.160 |
| September 25, 2024 | 3.111 |
| September 24, 2024 | 3.159 |
| September 23, 2024 | 3.157 |
| September 20, 2024 | 3.120 |
| September 19, 2024 | 3.164 |
| September 18, 2024 | 3.186 |
| September 17, 2024 | 3.180 |
| September 16, 2024 | 3.219 |
| September 13, 2024 | 3.280 |
| September 12, 2024 | 3.209 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5245
Minimum
Mar 18 2020
3.507
Maximum
Nov 05 2024
1.37
Average
1.129
Median
May 06 2021
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 15.85 |
| Compugen Ltd | 2.146 |
| Pluri Inc | -- |
| Can Fite Biofarma Ltd | 4.918 |
| BiomX Inc | 0.4628 |
Price to Book Value Related Metrics
| PS Ratio | 1.148 |
| Price to Free Cash Flow | 14.08 |
| Price | 17.08 |
| Earnings Yield | -4.98% |
| Market Cap | 19.36B |
| Operating PE Ratio | 5.165 |
| Normalized PE Ratio | 11.11 |